ANTX
Price
$3.37
Change
-$0.01 (-0.30%)
Updated
Oct 19 closing price
Capitalization
127.17M
17 days until earnings call
Intraday BUY SELL Signals
DNTH
Price
$74.54
Change
+$2.45 (+3.40%)
Updated
Oct 19 closing price
Capitalization
4.17B
16 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANTX vs DNTH

ANTX vs DNTH Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ANTX vs. DNTH commentary
Oct 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANTX is a Hold and DNTH is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ANTX with price predictions
Oct 16, 2026

ANTX in -17.67% downward trend, sliding for three consecutive days on October 14, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ANTX declined for three days, in 209 of 246 cases, the price declined further within the following month. The odds of a continued downward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ANTX as a result. In 55 of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.

The Moving Average Convergence Divergence Histogram (MACD) for ANTX turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 31 similar instances when the indicator turned negative. In 23 of the 31 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.

ANTX moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ANTX crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 69%.

The Aroon Indicator for ANTX entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +7.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where ANTX advanced for three days, in 198 of 235 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

ANTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.675) is normal, around the industry mean (2.835). P/E Ratio (-3.210) is within average values for comparable stocks, (-0.607). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (135.264) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. ANTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for DNTH with price predictions
Oct 19, 2026

Momentum Indicator for DNTH turns negative, indicating new downward trend

DNTH saw its Momentum Indicator move below the 0 level on September 15, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned negative. In 85 of the 94 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

DNTH moved below its 50-day moving average on September 15, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for DNTH crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 76%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DNTH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for DNTH entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where DNTH advanced for three days, in 240 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

DNTH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 30 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. DNTH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.557) is normal, around the industry mean (2.978). P/E Ratio (-17.580) is within average values for comparable stocks, (-0.692). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (134.267) among similar stocks. DNTH's P/S Ratio (2500.000) is slightly higher than the industry average of (438.009).

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
ANTX vs DNTH: Fundamental Ratings
ANTX
DNTH
OUTLOOK RATING
1..100
5051
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
77
Overvalued
PROFIT vs RISK RATING
1..100
10030
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
5550
P/E GROWTH RATING
1..100
1418
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANTX's Valuation (30) in the Managed Health Care industry is somewhat better than the same rating for DNTH (77) in the null industry. This means that ANTX’s stock grew somewhat faster than DNTH’s over the last 12 months.

DNTH's Profit vs Risk Rating (30) in the null industry is significantly better than the same rating for ANTX (100) in the Managed Health Care industry. This means that DNTH’s stock grew significantly faster than ANTX’s over the last 12 months.

DNTH's SMR Rating (96) in the null industry is in the same range as ANTX (98) in the Managed Health Care industry. This means that DNTH’s stock grew similarly to ANTX’s over the last 12 months.

DNTH's Price Growth Rating (50) in the null industry is in the same range as ANTX (55) in the Managed Health Care industry. This means that DNTH’s stock grew similarly to ANTX’s over the last 12 months.

ANTX's P/E Growth Rating (14) in the Managed Health Care industry is in the same range as DNTH (18) in the null industry. This means that ANTX’s stock grew similarly to DNTH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANTXDNTH
RSI
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
74%
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 18 days ago
84%
Bullish Trend 19 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 20, 2026
Stock price -- (ANTX: $3.37 vs. DNTH: $74.54)
Brand notoriety: ANTX and DNTH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANTX: 130% vs. DNTH: 96%
Market capitalization -- ANTX: $127.17M vs. DNTH: $4.17B
ANTX [@Biotechnology] is valued at $127.17M. DNTH’s [@Biotechnology] market capitalization is $4.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $127.22B. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANTX’s FA Score shows that 2 FA rating(s) are green while DNTH’s FA Score has 2 green FA rating(s).

  • ANTX’s FA Score: 2 green, 3 red.
  • DNTH’s FA Score: 2 green, 3 red.
According to our system of comparison, both ANTX and DNTH are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANTX’s TA Score shows that 4 TA indicator(s) are bullish while DNTH’s TA Score has 4 bullish TA indicator(s).

  • ANTX’s TA Score: 4 bullish, 6 bearish.
  • DNTH’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DNTH is a better buy in the short-term than ANTX.

Price Growth

ANTX (@Biotechnology) experienced а -21.63% price change this week, while DNTH (@Biotechnology) price change was -8.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.86%. For the same industry, the average monthly price growth was -18.66%, and the average quarterly price growth was -19.56%.

Reported Earning Dates

ANTX is expected to report earnings on Nov 05, 2026.

DNTH is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-7.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ANTX
Daily Signal:
Gain/Loss:
DNTH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MARS22.310.15
+0.68%
Roundhill Space & Technology ETF (MARS)
YBTC18.610.06
+0.32%
Roundhill Bitcoin Covered Call Strategy ETF (YBTC)
WEPN38.680.06
+0.15%
Nicholas Defense And Rare Earth Income ETF
NCIQ15.90N/A
N/A
Hashdex Nasdaq CME Crypto Index ETF
PXF75.89-0.41
-0.54%
Invesco RAFI Developed Markets ex-U.S. ETF (PXF)

ANTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANTX has been loosely correlated with DNTH. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ANTX jumps, then DNTH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANTX
1D Price
Change %
ANTX100%
-0.30%
DNTH - ANTX
39%
Loosely correlated
+3.40%
RLMD - ANTX
38%
Loosely correlated
+1.94%
XENE - ANTX
36%
Loosely correlated
+4.75%
SLDB - ANTX
34%
Loosely correlated
+7.05%
PASG - ANTX
31%
Poorly correlated
+0.86%
More